PURPOSE: To characterize the human choroid plexus (CP) papilloma cell line HIBCPP with respect to ABC export protein expression and function in order to evaluate its use as an in vitro model to study carrier-mediated transport processes at the CP. METHODS: Expression profiles of ABC transporters were studied by quantitative real-time PCR and Western Blot analysis. Functionality of transporters was investigated by means of uptake experiments and permeation studies carried out on permeable filter systems. In addition, immunohistochemistry served to study localization of ABCC1 and ABCC4. RESULTS: Both qPCR and Western Blot revealed that ABC transporters known to be expressed in CP are also expressed in HIBCPP cells. Immunohistochemistry confirmed basolateral expression of ABCC1. Functionality of ABCC1, ABCC4, ABCB1 and ABCG2 could be shown in uptake assays. CONCLUSIONS: Altogether, the HIBCPP cells promise to be a functional and relevant in vitro tool to investigate transport processes at the blood-cerebrospinal fluid barrier.
PURPOSE: To characterize the humanchoroid plexus (CP) papilloma cell line HIBCPP with respect to ABC export protein expression and function in order to evaluate its use as an in vitro model to study carrier-mediated transport processes at the CP. METHODS: Expression profiles of ABC transporters were studied by quantitative real-time PCR and Western Blot analysis. Functionality of transporters was investigated by means of uptake experiments and permeation studies carried out on permeable filter systems. In addition, immunohistochemistry served to study localization of ABCC1 and ABCC4. RESULTS: Both qPCR and Western Blot revealed that ABC transporters known to be expressed in CP are also expressed in HIBCPP cells. Immunohistochemistry confirmed basolateral expression of ABCC1. Functionality of ABCC1, ABCC4, ABCB1 and ABCG2 could be shown in uptake assays. CONCLUSIONS: Altogether, the HIBCPP cells promise to be a functional and relevant in vitro tool to investigate transport processes at the blood-cerebrospinal fluid barrier.
Authors: John D Allen; Arnold van Loevezijn; Jeany M Lakhai; Martin van der Valk; Olaf van Tellingen; Glen Reid; Jan H M Schellens; Gerrit-Jan Koomen; Alfred H Schinkel Journal: Mol Cancer Ther Date: 2002-04 Impact factor: 6.261
Authors: D Almeida-Santos; A C Duarte; I Gonçalves; Catarina L Ferreira; I Ferrer; Hiroshi Ishikawa; Christian Schwerk; Horst Schroten; Cecília R A Santos Journal: J Mol Neurosci Date: 2020-08-20 Impact factor: 3.444
Authors: Mateusz Pięt; A Zając; R Paduch; M Jaszek; M Frant; D Stefaniuk; A Matuszewska; K Grzywnowicz Journal: 3 Biotech Date: 2021-01-01 Impact factor: 2.406
Authors: André Furtado; Rafael Mineiro; Ana Catarina Duarte; Isabel Gonçalves; Cecília R Santos; Telma Quintela Journal: Int J Mol Sci Date: 2022-02-23 Impact factor: 5.923